Start the conversation
The S&P 500 turned 60 on Saturday. The index is celebrating with gains of more than 6% so far this year despite being down 10 points this morning.
U.S. economic data is being released at 10:00 a.m. today. The reports include factory orders and durable goods. The forecast for January is down 0.1% from the December's orders of 1.3%.
Dow futures were down more than 50 points this morning in anticipation of Trump's new immigration ban that is expected to be released today.
Now that we know what will be moving markets, here are three top stocks to watch today…
Top Stocks to Watch Today: Wells Fargo & Co. (NYSE: WFC)
Wells Fargo stock is down 1% in early morning trading after the U.S. Justice Department said it will target executives in a probe into fake customer accounts.
Urgent: An $80 billion cover-up? Feds use obscure loophole to threaten retirees… Read more…
In September, the company disclosed that as many as 2.1 million fake accounts were opened by staff without customer consent.
The unrealistic new account targets for employees were cited as the reason that staff were compelled to open the fraudulent accounts.
WFC stock is currently trading at $58.89, a gain of 6.9% year to date (YTD).
Top Stocks to Watch Today: Deutsche Bank AG (USA) (NYSE: DB)
Deutsche Bank stock is down 1.4% in early morning trading after announcing restructuring plans.
The bank will raise $8.48 billion with new shares. The dilution for existing shareholders will be about a third.
Previous capital increases have helped Deutsche Bank shore up its balance sheet, but it remains to be seen if the bank will need to continue to raise capital. Deutsche Bank has raised $21.20 billion in new capital since 2010 and is worth about $28 billion.
DB stock is currently trading at $19.35 for a gain of 6.9% YTD.
Top Stocks to Watch Today: TG Therapeutics Inc. (Nasdaq: TGTX)
TG Therapeutics stock is up 68% in early morning trading after announcing positive trial results.
The company announced that phase 3 trial results for its treatment of chronic lymphocytic leukemia met its target of safety and effectiveness.
TG Therapeutics is expected to release the full report of findings within the next three months.
Currently, TGTX stock is trading at $5.35 a share for a gain of 15% YTD.
Marijuana Investing: What You Need to Know… The legal marijuana market is going ballistic. Right now marijuana stocks are on fire, with peak gains quadrupling in value. And these are mostly small companies trading for under $10. Click here to learn more…